Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
41 - 50 of 892 results
  • Abstract
    Cannabidiol blocks morphine place preference in mice
    This study determined whether the cannabis constituent cannabidiol attenuates the development of morphine reward in the conditioned place preference paradigm. Mice received either saline or morphine in combination with increasing doses of cannabidiol us...
    Nov 13, 2017
  • Abstract
    Altered regional blood volume in chronic marijuana smokers.
    Marijuana remains the most commonly abused illicit substance in the United States, however, the effects of cannabis on cerebral blood volume (CBV) have not been fully examined. Given reported changes in frontal BOLD activation in marijuana smokers the objective of the present study was to examine both cerebral (frontal and temporal areas) and cerebellar blood volume during a period of supervised abstinence. Dynamic susceptibility contrast (DSC) MRI data were collected on eleven current, long-term marijuana users (MJ) between 6 hours and 36 hours after the subject's last reported cannabis use. Resting state CBV images were also acquired in 11 healthy comparison subjects (NCs). Data were acquired in the axial plane following a bolus of gadolinium contrast agent with a 1.5-Tesla GE Signa scanner. MJ smokers demonstrated significantly increased blood volumes in the left temporal area (p= 0.018) and in the cerebellum (p= 0.023) relative to control subjects. A regression analysis revealed that age was not signif...
    Nov 14, 2005
  • Abstract
    Estradiol enhances antinociceptive and motoric effects of THC.
    We have previously shown that cannabinoid agonists, including delta-9-tetrahydrocannabinol (THC), are more potent and in some cases more efficacious in female than in male rats, in terms of their antinociceptive and motoric effects (Tseng & Craft, Eur J Pharmacol 430:41, 2001). In the present study, we manipulated gonadal steroid hormone state in adulthood, to determine to what extent activational effects of gonadal steroids are responsible for sex differences in sensitivity to the behavioral effects of THC. Adult Sprague-Dawley rats were gonadectomized; half of the females were implanted s.c. with estradiol (1-mm capsule/rat), and half of the males were implanted with testosterone (10-mm capsule/100 g body weight), and the rest of the rats were implanted with blank capsules of comparable length and number. Three weeks later, rats were injected with THC (5 mg/kg i.p.) or vehicle (1:1:18 emulphor:ethanol:saline) and tested for antinociception (tail withdrawal and paw pressure tests) and motor behaviors (hor...
    Nov 13, 2005
  • Abstract
    Cannabidiol mediated regulation of alcohol consumption
    The aim of this study was to evaluate the effects of cannabidiol (CBD) in alcohol reinforcement, motivation and relapse in C57BL/6J mice. To this purpose, the effects of CBD (60 mg/kg i.p.) and ethanol on rectal temperature (3 g/kg p.o.), ethanol-handli...
  • Hippocampal Neurotoxicity of Δ9-Tetrahydrocannabinol | Journal of Neuroscience
    Marijuana consumption elicits diverse physiological and psychological effects in humans, including memory loss. Here we report that Δ9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is toxic for hippocampal neurons. Treatment of cultured neurons or hippocampal slices with THC caused shrinkage of neuronal cell bodies and nuclei as well as genomic DNA strand breaks, hallmarks of neuronal apoptosis. Neuron death induced by THC was inhibited by nonsteroidal anti-inflammatory drugs, including indomethacin and aspirin, as well as vitamin E and other antioxidants. Furthermore, treatment of neurons with THC stimulated a significant increase in the release of arachidonic acid. We hypothesize that THC neurotoxicity is attributable to activation of the prostanoid synthesis pathway and generation of free radicals by cyclooxygenase. These data suggest that some of the memory deficits caused by cannabinoids may be caused by THC neurotoxicity.
    Jul 15, 1998 Guy Chiu-Kai Chan
  • Abstract
    Basal and stress-induced cortisol and anxiety-like behavior after cannabidiol (CBD) injection in male and female zebrafish (Danio rerio)
    Anxiety disorders are becoming more prevalent every year, with almost 19% of the adult population suffering from some sort of anxiety disorder within the past year. Due to a variety of biological and social factors, females are more likely to be diagnos...
    Oct 21, 2019
  • SfN News Advocacy Press Release
    U.S. Travel Ban Raises Concerns for Scientists, Restricts Collaboration Efforts
    Week of July 2, 2018: Read the Latest Advocacy and Science News
    Jul 9, 2018
  • Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation | Journal of Neuroscience
    Evidence suggests that the phytocannabinoids Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) differentially regulate salience attribution and psychiatric risk. The ventral hippocampus (vHipp) relays emotional salience via control of dopamine (DA) neuronal activity states, which are dysregulated in psychosis and schizophrenia. Using in vivo electrophysiology in male Sprague Dawley rats, we demonstrate that intra-vHipp THC strongly increases ventral tegmental area (VTA) DA neuronal frequency and bursting rates, decreases GABA frequency, and amplifies VTA beta, gamma and ε oscillatory magnitudes via modulation of local extracellular signal-regulated kinase phosphorylation (pERK1–2). Remarkably, whereas intra-vHipp THC also potentiates salience attribution in morphine place-preference and fear conditioning assays, CBD coadministration reverses these changes by downregulating pERK1–2 signaling, as pharmacological reactivation of pERK1–2 blocked the inhibitory properties of CBD. These results identify vHipp...
    Oct 30, 2019 Roger Hudson
  • Abstract
    Pathway-specific synaptic plasticity of glutamatergic transmission in the nucleus accumbens caused by the psychoactive marijuana constituent, delta-9-tetrahydrocannabinol
    Cannabis is the most widely used illicit drug and its use is often associated with psychiatric disorders. THC is an agonist of cannabinoid 1 and 2 receptors (CB1R, CB2R), through which it acts on brain reward systems to increase dopamine (DA) neuron act...
    Nov 11, 2017
  • Abstract
    Marked neuroprotection by the marijuana derivative cannabidiol against piriform cortical brain damage resulting from prolonged seizures and status epilepticus in rats
    The present investigation assessed the neuroprotective efficacy of cannabidiol (CBD) in a kainic acid (KA) seizure model of temporal lobe epilepsy. Sixty-six male Sprague-Dawley rats were used. Each animal was housed individually in a clear polycarbonat...
    Oct 20, 2019
  • Previous
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience